摘要
目的：探讨强力宁联合小剂量阿维A治疗银屑病的临床疗效。方法：选取2014年7月～2016年1月在我院接受治疗的寻常型银屑病患者120例为研究对象,分为强力宁联合阿维A组及强力宁联合小剂量阿维A组,每组60例。比较治疗前后两组临床疗效、肝肾功能、血脂及用药不良反应情况。结果：强力宁联合小剂量阿维A组治疗总有效率为73.3%,显著高于强力宁联合阿维A组（P〈0.05）,差异有统计学意义。治疗过程中不良反应发生率为6.6%,显著低于强力宁联合阿维A组（P〈0.05）。结论：强力宁联合小剂量阿维A治疗寻常型银屑病疗效好,毒副作用少,值得临床推广。
Objective：To explore the clinical therapeutic effect on the treatment of Psoriasis with potenlin combined with low-dose acitretin. Methods：120 cases of Psoriasis vulgaris were divided into potenlin combined with acitretin group and potenlin combined with low-dose acitretin group according to different treating methods. To compare clinical curative effect and drug adverse reactions.Results：The total effective rate of potenlin combined with low-dose acitretin group was 73.3%,significantly higher than the other group（P〈 0.05）,the difference was statistically significant,the incidence of adverse reactions in the process of treatment was 6.6%,significantly lower than the other group（P〈0.05）. Conclusion：Potenlin combined with low-dose acitretin has better treatment of psoriasis vulgaris and less side effects.
出处
《北方药学》
2016年第8期22-24,共3页
Journal of North Pharmacy
基金
强力宁联合小剂量阿维A治疗银屑病临床研究基金编号:2015A020278
